Lista de obras - Nancy P Mendenhall - Dominio Público Uruguay

A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer

artículo científico publicado en 2014

A treatment planning comparison of highly conformal radiation therapy for pediatric low-grade brainstem gliomas

artículo científico publicado en 2013

ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma

artículo científico

ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II.

artículo científico publicado en 2016

ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.

artículo científico publicado en 2016

ACR appropriateness criteria follow-up of Hodgkin lymphoma.

artículo científico

Adjuvant radiotherapy for cutaneous melanoma

artículo científico publicado en 2008

Angiosarcoma after breast-conserving therapy: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART).

artículo científico publicado en 2013

Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy

artículo científico publicado en 2010

Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer

artículo científico publicado en 2007

Breast-conserving therapy (BCT) for early-stage breast cancer.

artículo científico publicado en 2004

Breast-conserving therapy in patients with bilateral breast cancer: do today's treatment choices burn bridges for tomorrow?

artículo científico publicado en 2005

Can Proton Therapy Improve the Therapeutic Ratio in Breast Cancer Patients at Risk for Nodal Disease?

artículo científico publicado en 2014

Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma

artículo científico publicado en 2010

Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer

artículo científico publicado en 2013

Consolidative Proton Therapy Following High-dose Chemotherapy and Autologous Stem Cell Transplant in an Adolescent with Relapsed Hodgkin Lymphoma

scientific article published on 01 June 2011

Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study

artículo científico

Definitive radiotherapy for prostate cancer

artículo científico publicado en 2008

Diagnostic Procedures and Guidelines for the Evaluation and Follow-up of Hodgkin's Disease

scientific article published on 01 July 1996

Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: A dosimetric comparison with photon-based stereotactic body radiotherapy

artículo científico publicado en 2010

Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer

artículo científico publicado en 2010

Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma

artículo científico

Erectile dysfunction after radiotherapy for prostate cancer

artículo científico publicado en 2009

Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger

artículo científico publicado en 2012

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer

artículo científico publicado en 2016

Head and neck osteosarcoma ⬇️

artículo científico publicado el 19 de noviembre de 2010

Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy

artículo científico publicado en 2014

Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons

artículo científico publicado en 2015

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study

artículo científico publicado en 2014

Is combined modality therapy necessary for advanced Hodgkin's disease? ⬇️

artículo científico publicado el 1 de junio de 1997

Is comprehensive lymphatic irradiation for low-grade non-Hodgkin's lymphoma curative therapy? long-term experience at a single institution ⬇️

artículo científico publicado el 1 de abril de 1997

Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?

artículo científico publicado en 2008

Late Effects After Radiotherapy for Childhood Low-grade Glioma.

artículo científico publicado en 2018

Late toxicity following craniospinal radiation for early-stage medulloblastoma

artículo científico

Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremities

artículo científico publicado en 1996

Local control in non-metastatic medulloblastoma

artículo científico publicado en 2014

Long-term complications of laparotomy in Hodgkin's disease

artículo científico publicado en 1994

Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experience

artículo científico publicado en 1997

Medulloblastoma: time–dose relationship based on a 30-year review ⬇️

artículo científico publicado el 1 de agosto de 1998

Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941–August 10, 2018

scholarly article and obituary

Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy

artículo científico publicado en 2011

Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons

artículo científico publicado en 2003

Postprostatectomy radiotherapy for prostate cancer

artículo científico publicado en 2009

Proton Therapy With Concurrent Chemotherapy for Non–Small-Cell Lung Cancer: Technique and Early Results

artículo científico publicado en 2012

Proton Therapy for Pediatric Hodgkin Lymphoma

artículo científico publicado en 2016

Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression

scientific article published on 11 May 2011

Proton therapy for skull base chordomas: an outcome study from the university of Florida proton therapy institute

artículo científico publicado en 2013

Proton therapy in the management of non-Hodgkin lymphoma.

artículo científico publicado en 2015

Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma

artículo científico publicado en 2014

Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity

artículo científico

Proton-based chemoradiation for synchronous bilateral non-small-cell lung cancers: A case report

artículo científico publicado en 2013

Radiation Therapy Modalities for Prostate Cancer

scientific article published on 01 August 2012

Radiation therapy for angiosarcoma: the 35-year University of Florida experience

artículo científico publicado en 2013

Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck

scientific article published on October 2009

Radiotherapy for pediatric brain tumors

artículo científico publicado en 1997

Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades

artículo científico publicado en 2018

Reducing Anesthesia and Health Care Cost Through Utilization of Child Life Specialists in Pediatric Radiation Oncology

artículo científico publicado en 2016

Response to radiation in chemotherapy-refractory monocytoid B-cell lymphoma: A case report

artículo científico publicado en 1994

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group

artículo científico publicado en 2012

Skin cancer of the head and neck with perineural invasion

artículo científico publicado en 2007

Skull base chordoma

artículo científico publicado en 2005

Solitary plasmacytoma of bone and soft tissue

artículo científico publicado en 1996

Solitary plasmacytoma of bone and soft tissues

artículo científico publicado en 2003

Subdiaphragmatic Hodgkin’s disease: The University of Florida experience ⬇️

artículo científico publicado el 1 de enero de 2002

Submandibular gland-sparing intensity-modulated radiotherapy

artículo científico publicado en 2014

Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose

artículo científico publicado en 2008

Urethral catheterization facilitates preradiation fiducial marker placement in postprostatectomy patients

artículo científico publicado en 2012

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trials

artículo científico publicado en 2013

When is elective pelvic lymph node irradiation indicated in definitive radiotherapy for localized prostate cancer?

artículo científico

Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation

artículo científico publicado en 2006

Lista de obras de Nancy P Mendenhall

A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer

A treatment planning comparison of highly conformal radiation therapy for pediatric low-grade brainstem gliomas

ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma

ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II.

ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.

ACR appropriateness criteria follow-up of Hodgkin lymphoma.

Adjuvant radiotherapy for cutaneous melanoma

Angiosarcoma after breast-conserving therapy: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART).

Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy

Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer

Breast-conserving therapy (BCT) for early-stage breast cancer.

Breast-conserving therapy in patients with bilateral breast cancer: do today's treatment choices burn bridges for tomorrow?

Can Proton Therapy Improve the Therapeutic Ratio in Breast Cancer Patients at Risk for Nodal Disease?

Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma

Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer

Consolidative Proton Therapy Following High-dose Chemotherapy and Autologous Stem Cell Transplant in an Adolescent with Relapsed Hodgkin Lymphoma

Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study

Definitive radiotherapy for prostate cancer

Diagnostic Procedures and Guidelines for the Evaluation and Follow-up of Hodgkin's Disease

Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: A dosimetric comparison with photon-based stereotactic body radiotherapy

Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer

Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma

Erectile dysfunction after radiotherapy for prostate cancer

Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer

Head and neck osteosarcoma ⬇️

Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy

Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study

Is combined modality therapy necessary for advanced Hodgkin's disease? ⬇️

Is comprehensive lymphatic irradiation for low-grade non-Hodgkin's lymphoma curative therapy? long-term experience at a single institution ⬇️

Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?

Late Effects After Radiotherapy for Childhood Low-grade Glioma.

Late toxicity following craniospinal radiation for early-stage medulloblastoma

Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremities

Local control in non-metastatic medulloblastoma

Long-term complications of laparotomy in Hodgkin's disease

Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experience

Medulloblastoma: time–dose relationship based on a 30-year review ⬇️

Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941–August 10, 2018

Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy

Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons

Postprostatectomy radiotherapy for prostate cancer

Proton Therapy With Concurrent Chemotherapy for Non–Small-Cell Lung Cancer: Technique and Early Results

Proton Therapy for Pediatric Hodgkin Lymphoma

Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression

Proton therapy for skull base chordomas: an outcome study from the university of Florida proton therapy institute

Proton therapy in the management of non-Hodgkin lymphoma.

Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma

Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity

Proton-based chemoradiation for synchronous bilateral non-small-cell lung cancers: A case report

Radiation Therapy Modalities for Prostate Cancer

Radiation therapy for angiosarcoma: the 35-year University of Florida experience

Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck

Radiotherapy for pediatric brain tumors

Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades

Reducing Anesthesia and Health Care Cost Through Utilization of Child Life Specialists in Pediatric Radiation Oncology

Response to radiation in chemotherapy-refractory monocytoid B-cell lymphoma: A case report

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group

Skin cancer of the head and neck with perineural invasion

Skull base chordoma

Solitary plasmacytoma of bone and soft tissue

Solitary plasmacytoma of bone and soft tissues

Subdiaphragmatic Hodgkin’s disease: The University of Florida experience ⬇️

Submandibular gland-sparing intensity-modulated radiotherapy

Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose

Urethral catheterization facilitates preradiation fiducial marker placement in postprostatectomy patients

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trials

When is elective pelvic lymph node irradiation indicated in definitive radiotherapy for localized prostate cancer?

Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation